# Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor

> **NCT06302023** · PHASE2 · COMPLETED · sponsor: **Khon Kaen University** · enrollment: 60 (actual)

## Conditions studied

- Pregnant Women Diagnosed With Threatened Preterm Labor

## Interventions

- **DIETARY_SUPPLEMENT:** Docosahexaenoic acid (DHA) 1000 mg

## Key facts

- **NCT ID:** NCT06302023
- **Lead sponsor:** Khon Kaen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2024-10-07
- **Final completion:** 2024-10-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06302023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06302023, "Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06302023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*